Attached files

file filename
EX-99.1 - PRESS RELEASE ISSUED BY MAKO SURGICAL CORP. ON JANUARY 7, 2013 - MAKO Surgical Corp.mako130067_ex99-1.htm




Washington, DC 20549







Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  January 7, 2013



MAKO Surgical Corp.

(Exact name of registrant as specified in its charter)


Delaware 001-33966 20-1901148
(State or other jurisdiction of
(Commission File Number) (I.R.S. Employer Identification No.)


2555 Davie Road

Fort Lauderdale, Florida 33317

(Address of principal executive offices and zip code)


Registrant’s telephone number, including area code:  (954) 927-2044



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Item 2.02.  Results of Operations and Financial Condition.


On January 7, 2013, MAKO Surgical Corp. (the “Company”) issued a press release (the “Press Release”) announcing for the fourth quarter and full year 2012 the number of RIO® Robotic Arm Interactive Orthopedic Systems sold, the number of MAKOplasty® Total Hip Arthroplasty (THA) applications sold, the percentage of domestic commercial installed base having the MAKOplasty THA application, and the number of MAKOplasty procedures performed. The foregoing description of the Press Release does not purport to be complete and is qualified in its entirety by reference to the full text of the Press Release, a copy of which is furnished herewith as Exhibit 99.1 and is incorporated into this Form 8-K by reference.


The information in this Form 8-K and the exhibit attached hereto pertaining to the Company’s operating results shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.


Item 9.01.  Financial Statements and Exhibits.


(d) Exhibits.


Exhibit No.   Description of Exhibit
99.1   Press Release issued by MAKO Surgical Corp. on January 7, 2013





Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



  MAKO Surgical Corp.
Date:  January 7, 2013 By: /s/ Fritz L. LaPorte
    Fritz L. LaPorte, Senior Vice President
of Finance and Administration, Chief
Financial Officer and Treasurer








Exhibit No.   Description of Exhibit
99.1   Press Release issued by MAKO Surgical Corp. on January 7, 2013